- Home
- ACET vs DGHI Comparison
ACET vs DGHI Comparison
Compare ACET & DGHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- DGHI
- Stock Information
- Founded
- ACET 1947
- DGHI 2017
- Country
- ACET United States
- DGHI United States
- Employees
- ACET N/A
- DGHI N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- DGHI Finance: Consumer Services
- Sector
- ACET Health Care
- DGHI Finance
- Exchange
- ACET Nasdaq
- DGHI Nasdaq
- Market Cap
- ACET 75.6M
- DGHI 61.7M
- IPO Year
- ACET N/A
- DGHI N/A
- Fundamental
- Price
- ACET $0.91
- DGHI $2.22
- Analyst Decision
- ACET Strong Buy
- DGHI Strong Buy
- Analyst Count
- ACET 4
- DGHI 1
- Target Price
- ACET $5.67
- DGHI $2.50
- AVG Volume (30 Days)
- ACET 513.3K
- DGHI 305.5K
- Earning Date
- ACET 11-06-2024
- DGHI 11-15-2024
- Dividend Yield
- ACET N/A
- DGHI N/A
- EPS Growth
- ACET N/A
- DGHI N/A
- EPS
- ACET N/A
- DGHI N/A
- Revenue
- ACET N/A
- DGHI $42,146,057.00
- Revenue This Year
- ACET N/A
- DGHI N/A
- Revenue Next Year
- ACET N/A
- DGHI N/A
- P/E Ratio
- ACET N/A
- DGHI N/A
- Revenue Growth
- ACET N/A
- DGHI 100.56
- 52 Week Low
- ACET $0.81
- DGHI $0.84
- 52 Week High
- ACET $3.62
- DGHI $2.34
- Technical
- Relative Strength Index (RSI)
- ACET 43.86
- DGHI 66.00
- Support Level
- ACET $0.85
- DGHI $1.41
- Resistance Level
- ACET $0.94
- DGHI $1.74
- Average True Range (ATR)
- ACET 0.08
- DGHI 0.18
- MACD
- ACET 0.00
- DGHI 0.05
- Stochastic Oscillator
- ACET 22.16
- DGHI 87.10
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About DGHI Digihost Technology Inc. Common Subordinate Voting Shares
Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.